November 10,2015

Press Contact:

Aaron Fobes, Julia Lawless (202) 224-4515

Hatch, Wyden Announce Hearing on Physician Owned Distributorships

WASHINGTON – Senate Finance Committee Chairman Orrin Hatch (R-Utah) and Ranking Member Ron Wyden (D-Ore.) today announced the Committee will hold a hearing on physician owned distributorships (PODs), entities in which physicians derive revenue from the sale of medical devices they prescribe to patients.  The hearing, titled “Physician Owned Distributors: Are They Harmful to Patients and Payers?” will be held on Tuesday, November 17, in Room 215 of the Dirksen Senate Office Building at 2:00 p.m. 

“While the vast majority of doctors operate with the highest ethical standards, those with a vested stake in medical device distributorships raise a number of concerning questions about the physician’s motivation in prescribing a procedure, as well as the overall cost to the health care system,” Hatch and Wyden said.  “When physicians have a financial incentive to recommend and perform a surgery, a potential conflict of interest can occur and jeopardize the health of patients.  With this hearing, the Committee will have the opportunity to hear views on all sides of the debate, and we look forward to a constructive conversation on how to ensure major health decisions are made in the best interest of the patient and not the physician’s pocketbook.”  


The witnesses for Tuesday’s hearing are:

  • Dr. Scott Lederhaus, President, Association for Medical Ethics, Monarch Beach, CA
  • Dr. John Steinmann, Board Advisor, American Association of Surgical Distributors, Redlands, CA
  • Ms. Suzie Draper, Vice President of Business Ethics and Compliance, Intermountain Healthcare, Salt Lake City, UT
  • Mr. Kevin Reynolds, Son of a Patient of a Surgeon Affiliated with a Physician Owned Distributor, Ventura, Ventura, CA


Senate Finance Committee




Hearing on Physician Owned   Distributorships (PODs)



215 Dirksen Senate Office Building


Washington, D.C. 20510


Tuesday, November 17, 2015


2:00 p.m.

For media inquiries and additional information, including webcast and testimony details, please visit: